- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Bacil Pharma's board has approved key changes following a recent meeting. The company appointed M/s Sarang Shivajirao Chavan & Associates as its new Statutory Auditor for the financial year 2025-2026. Additionally, Mr. Vivek Mukesh Yadav has been appointed as an Independent Director, bringing significant experience in finance, accounts, and corporate management. This expertise is expected to bolster the company's financial and operational strategy. These appointments are crucial for strengthening the company's governance framework and financial oversight, providing added value to stakeholders.